Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CAR-T
Research
CAR-T for brain cancer extends survival in phase 1 trial
Mustang Bio and City of Hope’s CAR-T therapy for glioblastoma led to stable disease in half of the subjects, with one surviving beyond five years.
Helen Floersh
Mar 12, 2024 9:00am
Galapagos halts lupus CAR-T work, confirms 100 layoffs this year
Feb 23, 2024 8:28am
Q&A: Symphony founder's immunotherapy sponges set for space test
Feb 16, 2024 7:00am
Using cancer's 'superpower' to boost T-cell therapies in mice
Feb 12, 2024 3:30pm
BioNTech pays Autolus $250M to use manufacturing, CAR-T tech
Feb 8, 2024 9:17am
Takeda drops cancer candidates amid shifting treatment landscape
Feb 2, 2024 5:33am